期刊文献+

艾司洛尔和硝普钠控制性降压对鼻内窦手术病人血利尿钠肽的影响

Study on esmolol and sodium nitroprusside's hypotension control on atrial and brain natriuretic peptide in patients undergoing endonasal sinus surgery
下载PDF
导出
摘要 目的研究控制性降压对鼻内窦术病人血浆心房利尿钠肽(ANP)和脑利尿钠肽(BNP)水平的影响。方法选择45例无心血管疾病拟实行鼻内窦术病人随机分成三组,每组15例即控制性降压艾洛尔组和硝普钠组平均动脉压(MAP)维持在50-55mmHg;对照组平均动脉压维持在70~80mmHg。在下列各时点测定血ANP和BNP浓度:术前(T1)、手术结束时(T2)、2h(T3)、24h(T4)、48h(T5)。结果术前ANP和BNP水平均在正常范围并且三组水平均相似,与对照组(ANP5.31±2.32ug/ml;BNP13.26±8.98ug/ml,P〈0.01)相比艾司洛尔组(ANP2.46±0.75ug/ml;BNP4.34±3.06ug/m1)和硝普钠组(ANP2.48±0.92ug/ml;BNP4.49±3.21ug/m1)T2,T3时点ANP和BNP浓度均下降,并且失血量减少和手术时间缩短。结论控制性降压减少心血管健康病人利尿钠肽的释放。这种作用是通过降低全身阻力和灌注压引起心室充盈压下降引起而实现。 Objective The study was designed to assess serum concentration of atrial and brain natriuretic peptide in patients undergoing endonasal sinus surgery under controlled hypotension. Methods We studied 45 patients without cardiovascular history, scheduled for elective endonasal sinus surgery. Patients were allocated to one of three groups: controlled hypotension was induced either by using esmolol (n=20) or sodium nitroprusside ( n = 20) with a mean arterial pressure of 50-55 mmHg. In the control group ( n = 20), mean arterial pressure was adjusted to 70-80 mmHg. Atrial and brain natriuretic peptides(ANP,BNP)were measured preoperatively (T1), at the end of surgery (T2), 2h (T3), 24 h (T4) and 48 h (T5) pestoperatively. Results Preoperative atrial and brain natriuretic peptide plasma levels were within normal ranges and similar between all groups. Patients treated with esmolol (ANP:2.46±0.75 ug/ml; BNP: 4.34±3.06 ug/ml) and sodium nitropusside (ANP: 2.48± 0.92 ug/ml;BNP: 4.49±3.21 ug/ml ) showed significantly lower concentrations of atrial and brain natriuretic peptide at T2 and T3 compared with controls (ANP: 5.31±2.32 ug/ml; BNP: 13.26±8.98 ug/ml, P 〈 0.01 ) as well as a reduction in blood loss and duration of surgery. Conclusion Controlled hypotension decreases the release of natriuretic peptides in cardiovascular healthy patients. This effect may be contributed by changes in cardiac filling pressure due to lower systemic resistance and diminished perfusion pressure.
出处 《浙江临床医学》 2008年第9期1181-1183,共3页 Zhejiang Clinical Medical Journal
关键词 控制性降压 艾司洛尔 硝普钠 心房利尿钠肽 脑利尿钠肽 Controlled hypotension Esmolol Nitropmsside Atrial natriuretic peptide Brain natriuretic peptide
  • 相关文献

参考文献9

  • 1Sharroek NE, Mineo R, Urquhart B, et al. The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg , 1993, 76:580 ~ 584.
  • 2Piper SN, Haisch G, Kumle B, et al. Effects of esmolol and sodium nitroprusside - induced controlled hypotension on hepatocellular integrity in patients undergoing endonasal sinus surgery. Anasthesiol Intensivmed Notfallmed Sehnerzther , 2003, 38 : 781 - 786.
  • 3Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature, 1988,332:78 - 81.
  • 4Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B - type natriuretic peptide in comparison with those of A - type natriurefic peptide in normal subjects and patients with heart failure. Circulation, 1994, 90: 195 - 203.
  • 5Richards AM, Lainchbury JG, Troughton RW, et al. Clinical applications of B - type natriuretic peptides. Trends Endoirinol Metab, 2004,15:170 - 174.
  • 6何峰,宋从周.脑钠肽与心力衰竭的诊治[J].中国心血管杂志,2006,11(3):229-231. 被引量:13
  • 7Davis ME, Richards AM, NicholU MG, et al. Introduction of metoprolol increases plasma B - type cardiac natriuretic peptides in mild, stable heart failure. Circulation, 2006, 113:977 - 985.
  • 8Htyniewicz K, Androne AS, Hudaihed A, et al. Comparative effects of carvedilol and metoprolol onregional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure. Circulation ,2003, 108:971-976.
  • 9Piper SN, Sutcner SW, Maleck WH, et al. Effects of sodium nitroprusside- induced controlled hypotension on pancreatic function assessed by pancreatitis - associated protein in patients undergoing radical prostatectomy. Eur J Anaesthesiol ,2002, 19: 609 - 613.

二级参考文献18

  • 1Braunwald 陈灏珠.心脏病学[M](第五版)[M].北京:人民卫生出版社,1999.363-368.
  • 2Peter A,Omland T,Maisel AS. B-type rlatriuretic peptides, a diagnostic break through for clinicians[J]. Rev Cardiovasc Med,2003,4 : 72-80.
  • 3Cowie MR, Mendez GF. BNP and congestive heart failure[J].Prog Cardiovasc Dis, 2002,44 : 293-321.
  • 4Maisel AS, Krishnaswamy P, Nowak RM, et al. For the breathing not properly multinational study investigators-rapid measurement of B-type natriuretie peptide in the emergengey diagnosis of heart failure[J]. N Engl J Med, 2002,347 : 161-167.
  • 5Berdague P, Caffin PY, Barazer I,et al. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients[J]. Am Heart J, 2006, 151:690-698.
  • 6Nakamura M, Sakai T, Osawa M, et al. Comparison of positive cases for B-type natriuretic peptide and ECG testing for identification of precursor forms of heart failure in an elderly population[J].Int Heart J, 2005,46:477-487.
  • 7McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction[J . Lancet, 1998,351:9-13.
  • 8Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide ( N-BNP ) concentrations[J]. Lancet, 2000, 355 : 1126-1130.
  • 9Murdoch DR, McDonagh TA, Byme J, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretie peptide concentration: randomized comparison of the hemodynamie and neuroendocrine effects of tailored versus empirical therapy[J]. Am Heart J, 1999 , 138 : 1126-32.
  • 10Publication Committee for the VMAC Investigation. Intravenous nesiritide vs. mitroglycerin for treament of decompensated congestive heart failure randomized controlled trial[J]. JAMA, 2002,287: 1531-1535.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部